Background: Sheehan’s syndrome is a rare but serious form of hypopituitarism resulting from ischemic necrosis of the anterior pituitary gland, typically triggered by severe postpartum hemorrhage. Its clinical presentation is often nonspecific and insidious, leading to delayed diagnosis and irreversible complications. This case report highlights the diagnostic challenges and the importance of early hormonal evaluation in at-risk patients.

Case Report: A 43-year-old female presented with secondary amenorrhea and persistent headaches two years after a complicated delivery marked by severe postpartum hemorrhage and agalactorrhea. Endocrine evaluation revealed panhypopituitarism, with deficiencies in corticotropic, thyrotropic, gonadotropic, somatotropic, and lactotropic axes. Magnetic resonance imaging (MRI) confirmed pituitary atrophy with empty sella turcica, consistent with Sheehan’s syndrome. Hormone replacement therapy (HRT) was initiated, including glucocorticoids, levothyroxine, and estrogen-progestin, with plans for growth hormone replacement and bone health monitoring.

Discussion: This case underscores the critical need for a high index of clinical suspicion in women with a history of postpartum hemorrhage and lactation failure. Early recognition and prompt initiation of HRT can prevent long-term complications such as adrenal crisis, osteoporosis, and impaired quality of life. Multidisciplinary collaboration between obstetricians, endocrinologists, and radiologists is essential for optimal management.

Conclusion: Sheehan’s syndrome remains underdiagnosed due to its subtle and nonspecific symptoms. Heightened awareness among healthcare providers, especially in the context of postpartum hemorrhage, is crucial for timely intervention. Lifelong hormonal monitoring and individualized HRT are key to improving outcomes in affected patients.